MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy
ConclusionsThe identification of specific miRNAs offers a novel diagnostic perspective for recognizing intramyocardial inflammation within virus-negative DCMi patients. Furthermore, these miRNAs hold promise as potential candidates for tailored therapeutic strategies in the context of virus-negative DCMi.
Source: ESC Heart Failure - Category: Cardiology Authors: Ganna Aleshcheva,
Christian Baumeier,
Dominik Harms,
C. ‐Thomas Bock,
Felicitas Escher,
Heinz‐Peter Schultheiss Tags: Original Article Source Type: research